SCHUYLER STUMP: Open Payments
NPI 1407314016 · WICHITA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$881 in 38 payments from 14 companies in 2025. Trend: 2023 $1,524 · 2024 $1,485 · 2025 $881
Food & beverage: $791Education: $90
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 7 | $188 |
| GENZYME CORPORATION | 4 | $127 |
| Lilly USA, LLC | 4 | $89 |
| ABBVIE INC. | 4 | $76 |
| Arcutis Biotherapeutics, Inc. | 1 | $76 |
| PFIZER INC. | 3 | $50 |
| Novartis Pharmaceuticals Corporation | 3 | $46 |
| Amgen Inc. | 2 | $45 |
| LEO Pharma Inc. | 2 | $41 |
| E.R. Squibb & Sons, L.L.C. | 2 | $40 |
Products named: TREMFYA, DUPIXENT, Zoryve, TALTZ, COSENTYX, OTEZLA, ANZUPGO, Sotyktu.
Industry payments across KS — which companies pay providers there.
